Evidence map›Paper›PMID 40642570›Full record

ArticleHealth science reports2025

Primary Immunodeficiency Registry System: The Minimum Data Set Designing Phase-A Systematic Review and Quantitative Delphi Study.

Saman Mohammadpour, Hassan Emami, Sima Shokri, Rafat Bagherzadeh, Soqrat Omari Shekaftik, Zanko Hosseini

Abstract read
In one paragraph

Article in Health science reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Saman MohammadpourDepartment of Health Information Technology and Management, School of Allied Medical Sciences Shahid Beheshti University of Medical Sciences Tehran Iran.ORCID https://orcid.org/0000-0002-6042-9154
Hassan EmamiDepartment of Health Information Technology and Management, School of Allied Medical Sciences Shahid Beheshti University of Medical Sciences Tehran Iran.ORCID https://orcid.org/0000-0003-4309-5049
Sima ShokriDepartment of Allergy and Clinical Immunology, Rasool e Akram Hospital Iran University of Medical Sciences Tehran Iran.ORCID https://orcid.org/0000-0002-2176-3934
Rafat BagherzadehDepartment of English Language, School of Health Management and Information Sciences Iran University of Medical Sciences Tehran Iran.ORCID https://orcid.org/0000-0002-1649-2615
Soqrat Omari ShekaftikDepartment of Occupational Health Engineering, School of Public Health Tehran University of Medical Sciences Tehran Iran.ORCID https://orcid.org/0000-0003-1122-1223
Zanko HosseiniDepartment of Health Information Management, School of Medicine Ardabil University of Medical Sciences Ardabil Iran.ORCID https://orcid.org/0009-0008-4115-2461

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Aims: Registries are powerful tools for data management. Designing a minimum data set as the first step in registry development helps collect relevant and efficient data. The aim of this study was to develop a minimum data set for the primary immunodeficiency registry system. Methods: This cross-sectional study was conducted at two stages in 2023. In the first stage, primary data elements were extracted from related literature. In the second stage, based on the data elements extracted from the first stage, a questionnaire was developed. Then, using the questionnaire and the Quantitative Delphi Method, the minimal data set on primary immunodeficiency was obtained from 10 asthma and allergy specialists. Results: In the first stage, the initial minimum data set consisted of 198 data elements, which were categorized into two categories: administrative and clinical. Administrative data were classified into two categories: demographic and patient index. Clinical data were categorized into four categories: patient history, physical examination, tests, and diagnosis. In the second stage, eight elements were removed during the first round of Delphi. One element was removed in the second round of Delphi. In the first round of Delphi, 13 elements were recommended. In the second round of Delphi, all the recommended elements were included in the final list of the minimum data set. Finally, 202 data elements were selected as the final minimum data set. Conclusion: The created primary immunodeficiency minimum data set is expected to improve decision-making by clinicians and policymakers, and also improve scientific research in this field.

Indexed as

MDSminimum data setPIDprimary immunodeficiencyregistry

Identifiers

PMID40642570
PMCPMC12241437

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.